Skip to main content
Clifford Hudis, MD, Oncology, Alexandria, VA

Clifford A Hudis MD

Oncology•Alexandria, VA

Breast Cancer, Hematologic Oncology

CEO, American Society of Clinical Oncology

Request Appointment

  • 2318 Mill RoadSuite 800Alexandria, VA 22314

  • Book by Phone+1(765) 305-5100

Overview of  Dr. Hudis

Dr. Clifford Hudis is an oncologist based in New York, specializing in breast cancer and hematologic oncology. He completed his fellowship in hematology and medical oncology at Memorial Sloan Kettering Cancer Center, where he served as faculty and, from 1998 to 2016, as Chief of the Breast Medicine Service. He was also a Professor of Medicine at the Weill Cornell Medical Collaged. Since 2016 he has served as CEO of the American Society of Clinical Oncology while continuing to volunteer as a Consultant on the Breast Medicine Service at MSKCC. His research was focused on drug and regimen development for all stages of breast cancer as well as prevention and he has published extensively in journals like the Journal of Clinical Oncology and has received multiple awards, including recognition as one of America's Top Doctors by Castle Connolly over many years.

Education & Training

  • Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer CenterFellowship, Hematology and Medical Oncology, 1988 - 1991
  • Drexel University College of Medicine/Hahnemann University Hospital
    Drexel University College of Medicine/Hahnemann University HospitalResidency, Internal Medicine, 1983 - 1985
  • MCP-Hahnemann College of Medicine
    MCP-Hahnemann College of MedicineClass of 1983

Certifications & Licensure

  • FL State Medical License
    FL State Medical License 1990 - Present
  • NY State Medical License
    NY State Medical License 1987 - 2028
  • NJ State Medical License
    NJ State Medical License 2022 - 2027
  • PA State Medical License
    PA State Medical License 1984 - 1992
  • Internal Medicine
    American Board of Internal Medicine Internal Medicine
  • Medical Oncology
    American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification Sunrise Ambulatory Care, Allscripts, 2016-2017
  • CMS Meaningful Use Stage 1 Certification MyMSK, Memorial Sloan Kettering, 2016-2017
  • America's Top Doctors Castle Connolly, 2006-2014

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Science and Society: Fifty Years Later-The 2014 Presidential Address  
    Hudis C, J Clin Oncol, 1/10/2015
  • A phase II open-label study of ganetespib, a novel heat shock protein 90 inhibitor for patients with metastatic breast cancer  
    Jhaveri K, Chandarlapaty S, Lake D, Gilewski T, Robson M, Goldfarb S, Drulinsky P, Sugarman S, Leiblich CW, Fasano J, Moynahan ME, D'Andrea G, Lim K, Reddington L, Haq..., Clin Breast Cancer, 1/1/2014
  • Associations among survivorship care plans, experiences of survivorship care, and functioning in older breast cancer survivors: CALGB/Alliance 369901  
    Faul LA, Luta G, Sheppard V, Isaacs C, Cohen HJ, Muss HB, Yung R, Clapp JD, Winer E, Hudis C, Tallarico M, Wang J, Barry WT, Mandelblatt JS, J Cancer Surviv, 1/1/2014

Books/Book Chapters

  • Diseases of the Breast 
    Chapter: Implications of breast cancer. 
    Page 700 - 708Gucalp A, Morris PG, Hudis CA, Dannenberg AJEditors: Harris JR, Lippman ME, Morrow, M Osborne CK.Lippincott, Williams & Wilkins, Philadelphia, PAEdition 5th,2014
  • Diseases of the Breast 
    Chapter: Adjuvant systemic chemotherapy in early breast cancer. 
    Page 635 - 648Hudis CA, Dang CEditors: Harris JR, Lippman ME, Morrow, M Osborne CK.Lippincott, Williams & Wilkins, Philadelphia, PAEdition 5th,2014
  • Future of Medicine 
    Chapter: Advances in Management of Triple Negative. 
    Hudis C, Traina TAEditors: Tiffany Traina.Future Medicine Ltd, London, United Kingdom2011

Lectures

  • Continuing Medical Education (CME) Comprehensive Oncology Review 
    Continuing Medical Education Institute, Inc, Seattle, Washington - 9/22/2012

Other

  • Dose-dense chemotherapy: ready for prime time. 
    Dang CT and Hudis CA, Breast Cancer Online
    http://www.bco.org/my_bco.asp
    1/1/2005
  • Letrozole after tamoxifen improves disease-free survival from women with breast cancer (expert comments). 
    Hudis C
    www.breastcancercare.org

Press Mentions

  • China’s Rise in Drug Development Looms Over U.S.
    China’s Rise in Drug Development Looms Over U.S.May 30th, 2026
  • "Where the Real Answer Lies”: How CNS Disease Influences EGFR-Mutated NSCLC Treatment Decisions
    "Where the Real Answer Lies”: How CNS Disease Influences EGFR-Mutated NSCLC Treatment DecisionsDecember 19th, 2025
  • How the AI-Powered ASCO® Guidelines Assistant Is Improving Clinical Decision-Making
    How the AI-Powered ASCO® Guidelines Assistant Is Improving Clinical Decision-MakingSeptember 4th, 2025

Insurance Accepted

  • Aetna Choice POS II
    Aetna HMO
    BCBS Blue Card PPO
    BCBS Illinois PPO
    CIGNA HMO
    CIGNA Open Access
    CIGNA PPO
    Empire BCBS HMO
    Empire BCBS PPO
    GHI PPO
    Great West PPO
    Humana ChoiceCare Network PPO
    Multiplan PHCS PPO
    Multiplan PPO
    MVP Healthcare PPO
    Oxford Health Freedom
    Oxford Health Liberty
    PacificSource Preferred PSN
    QualCare HMO
    QualCare PPO
    United Healthcare - Direct Choice Plus POS
    United Healthcare - Direct Options PPO
  • Please verify your coverage with the provider's office directly when scheduling an appointment

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence:

Dr. Clifford Hudis, Dr. Clifford Hudis, MD, Dr. C Hudis, Dr. Clifford A Hudis